Sign in

CIK 0001649989

  • Non-accelerated filer
  • Smaller reporting company

Outlook Therapeutics, Inc.

Sign in to watch
Ticker
OTLK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
DE
Entity type
Operating
EIN
383982704
Phone
+1 609-619-3990
Business address
111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
Former names
Oncobiologics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 71 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-10-05 Gangolli Julian S Director Grant or award · Stock Option (Right to Buy) +44,466 44,466
2021-10-05 Haddadin Yezan Munther Director Grant or award · Stock Option (Right to Buy) +47,335 47,335
2021-10-05 Sukhtian Faisal Ghiath Director Grant or award · Stock Option (Right to Buy) +44,753 44,753
2021-10-05 HILZINGER KURT J Director Grant or award · Stock Option (Right to Buy) +34,425 34,425
2021-07-06 TRENARY C RUSSELL III CEO and President Grant or award · Stock Option (Right to Buy) +4,000,000 4,000,000
2021-04-20 KENYON LAWRENCE A CEO, Pres, CFO, Treas & Secy Purchase +10,000 $1.83 $18K 18,926
2021-04-19 Haddadin Yezan Munther Director Purchase +10,000 $1.82 $18K 20,000
2021-04-19 Sukhtian Faisal Ghiath Director Purchase +10,000 $1.82 $18K 20,000
2021-03-24 Huang Andong Director Grant or award · Stock Option (Right to Buy) +20,873 20,873
2021-03-24 Auffarth Gerd Director Grant or award · Stock Option (Right to Buy) +20,873 20,873
2021-03-24 Gangolli Julian S Director Grant or award · Stock Option (Right to Buy) +20,873 20,873
2021-03-24 Haddadin Yezan Munther Director Grant or award · Stock Option (Right to Buy) +20,873 20,873
2021-03-24 Sukhtian Faisal Ghiath Director Grant or award · Stock Option (Right to Buy) +20,873 20,873
2021-03-24 THURMAN RANDY H Director Grant or award · Stock Option (Right to Buy) +20,873 20,873
2021-03-24 HILZINGER KURT J Director Grant or award · Stock Option (Right to Buy) +20,873 20,873
2021-02-23 Evanson Jeff Chief Commercial Officer Sale −8,554 $2.09 $18K 1,141,930
2021-02-23 Dagnon Terry Chief Operating Officer Sale −15,900 $2.09 $33K 1,127,857
2021-02-12 Evanson Jeff Chief Commercial Officer Sale −56,973 $2.55 $145K 1,150,484
2021-02-12 Dagnon Terry Chief Operating Officer Sale −63,700 $2.55 $162K 1,143,757
2021-02-10 Sukhtian Ghiath M. Director Grant or award +1,013,627 $1.00 $1.0M 11,834,257

Page 9 of 14 · 276 trades